BRCA1 represses amphiregulin gene expression.

BRCA1, the breast cancer- and ovarian cancer-specific tumor suppressor, can be a transcriptional repressor or a transcriptional activator, depending on the promoter context. To identify the genes activated or repressed by BRCA1, we have analyzed microarray results from cells depleted of BRCA1 and revealed a number of genes regulated by BRCA1 on the level of transcription. Among the genes repressed by BRCA1, we have identified amphiregulin (AREG) and early growth response-1 (EGR1). Results indicate that BRCA1 regulates AREG transcription directly through binding to the AREG promoter, however, we could not detect BRCA1 on the EGR1 promoter, suggesting that EGR1 is indirectly regulated by BRCA1. In an attempt to identify the mechanism of the AREG transcriptional repression by BRCA1, we have mapped two independent BRCA1 response elements on the AREG located at positions -202/-182 and +19/+122. BRCA1 depletion leads to induction of the AREG protein. Taken together, our data build the connection between BRCA1 loss of function and AREG upregulation-a change in gene expression often observed in breast cancer.

[1]  M. Espié,et al.  Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal–epithelial interactions , 2001, The Journal of pathology.

[2]  M. Leonard,et al.  Hypoxia induces epithelial amphiregulin gene expression in a CREB-dependent manner. , 2006, American journal of physiology. Cell physiology.

[3]  C. Angeletti,et al.  Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  J. Parvin,et al.  BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A , 1998, Nature Genetics.

[5]  A. Venkitaraman.  Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002 .

[6]  Jonathan D. Licht,et al.  BRCA1 Augments Transcription by the NF-κB Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit* , 2003, Journal of Biological Chemistry.

[7]  Steven P. Gygi,et al.  BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number , 2004, Molecular and Cellular Biology.

[8]  H. Friess,et al.  Induction and expression of amphiregulin in human pancreatic cancer. , 1994, Cancer research.

[9]  G. Lenoir,et al.  Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region , 1998, Oncogene.

[10]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[11]  N. Normanno,et al.  Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas. , 2002, International journal of oncology.

[12]  David C. Lee,et al.  Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. , 1999, Development.

[13]  N. Normanno,et al.  Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. , 1995, Endocrinology.

[14]  P. Transidico,et al.  Clathrin-independent endocytosis of ubiquitinated cargos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Merlo,et al.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.

[16]  W. Gerald,et al.  The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin , 1999, Cell.

[17]  L. Starita,et al.  Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells , 2003, Oncogene.

[18]  A. Harris,et al.  Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. , 1993, Cancer research.

[19]  J. Parvin,et al.  Factors associated with the mammalian RNA polymerase II holoenzyme. , 1998, Nucleic acids research.

[20]  P. Mullan,et al.  The role of BRCA1 in transcriptional regulation and cell cycle control , 2006, Oncogene.

[21]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[22]  C. Osborne,et al.  Location of BRCA1 in Human Breast and Ovarian Cancer Cells , 1996, Science.

[23]  A. Horwitz,et al.  BRCA1 DNA-binding activity is stimulated by BARD1. , 2006, Cancer research.

[24]  Li‐Wha Wu,et al.  Amphiregulin as a tumor promoter for oral squamous cell carcinoma: involvement of cyclooxygenase 2. , 2006, Oral oncology.

[25]  R. Young,et al.  BRCA1 is a component of the RNA polymerase II holoenzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Horwitz,et al.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase , 2007, Proceedings of the National Academy of Sciences.

[27]  W. Forrester,et al.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Kimura,et al.  Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  I. Verma,et al.  Transcriptional activation by BRCA1 , 1996, Nature.

[30]  J. Welsh,et al.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Couch.  Genetic Epidemiology of BRCA1 , 2004, Cancer biology & therapy.

[32]  S. Elledge,et al.  Direct DNA binding by Brca1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Ashworth,et al.  Hallmarks of 'BRCAness' in sporadic cancers , 2004, Nature Reviews Cancer.

[34]  A. Hollestelle,et al.  BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. , 2006, Cancer research.

[35]  X. Wang,et al.  Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. , 1999, Molecular cell.

[36]  A. Horwitz,et al.  Direct Stimulation of Transcription Initiation by BRCA1 Requires Both Its Amino and Carboxyl Termini* , 2006, Journal of Biological Chemistry.

[37]  S. Ethier,et al.  Autocrine and Juxtacrine Effects of Amphiregulin on the Proliferative, Invasive, and Migratory Properties of Normal and Neoplastic Human Mammary Epithelial Cells* , 2006, Journal of Biological Chemistry.

[38]  J. Prieto,et al.  Amphiregulin: a new growth factor in hepatocarcinogenesis. , 2007, Cancer letters.

[39]  Wen-Hwa Lee,et al.  Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. , 2006, Cancer cell.

[40]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[41]  J. Parvin,et al.  The BRCA1 E3 Ubiquitin Ligase Controls Centrosome Dynamics , 2006, Cell cycle.

[42]  D. Bostwick,et al.  Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 93 cases , 2004, The Prostate.

[43]  S. Badve,et al.  The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. , 2005, Carcinogenesis.

[44]  L. Starita,et al.  The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. , 2003, Current opinion in cell biology.

[45]  N. Normanno,et al.  The role of amphiregulin in breast cancer , 2004, Breast Cancer Research and Treatment.

[46]  Rosette Lidereau,et al.  Molecular Profiling of Inflammatory Breast Cancer , 2004, Clinical Cancer Research.

[47]  C. Disteche,et al.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity , 1990, Molecular and cellular biology.

[48]  Z. Werb,et al.  Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin , 2005, Development.